JP2018511616A5 - - Google Patents

Download PDF

Info

Publication number
JP2018511616A5
JP2018511616A5 JP2017553122A JP2017553122A JP2018511616A5 JP 2018511616 A5 JP2018511616 A5 JP 2018511616A5 JP 2017553122 A JP2017553122 A JP 2017553122A JP 2017553122 A JP2017553122 A JP 2017553122A JP 2018511616 A5 JP2018511616 A5 JP 2018511616A5
Authority
JP
Japan
Prior art keywords
alkyl
aryl
compound according
unsubstituted
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017553122A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018511616A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/027549 external-priority patent/WO2016168472A1/en
Publication of JP2018511616A publication Critical patent/JP2018511616A/ja
Publication of JP2018511616A5 publication Critical patent/JP2018511616A5/ja
Pending legal-status Critical Current

Links

JP2017553122A 2015-04-14 2016-04-14 短鎖デヒドロゲナーゼ活性を調節する組成物および方法 Pending JP2018511616A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562147305P 2015-04-14 2015-04-14
US62/147,305 2015-04-14
PCT/US2016/027549 WO2016168472A1 (en) 2015-04-14 2016-04-14 Compositions and methods of modulating short-chain dehydrogenase activity

Publications (2)

Publication Number Publication Date
JP2018511616A JP2018511616A (ja) 2018-04-26
JP2018511616A5 true JP2018511616A5 (enExample) 2019-05-30

Family

ID=57127188

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017553122A Pending JP2018511616A (ja) 2015-04-14 2016-04-14 短鎖デヒドロゲナーゼ活性を調節する組成物および方法

Country Status (8)

Country Link
US (4) US20180118756A1 (enExample)
EP (1) EP3283074A4 (enExample)
JP (1) JP2018511616A (enExample)
CN (1) CN108012528A (enExample)
AU (1) AU2016248080A1 (enExample)
CA (1) CA2982784A1 (enExample)
HK (1) HK1250651A1 (enExample)
WO (1) WO2016168472A1 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11690847B2 (en) 2016-11-30 2023-07-04 Case Western Reserve University Combinations of 15-PGDH inhibitors with corticosteroids and/or TNF inhibitors and uses thereof
US11718589B2 (en) 2017-02-06 2023-08-08 Case Western Reserve University Compositions and methods of modulating short-chain dehydrogenase
US12336982B2 (en) 2018-11-21 2025-06-24 Rodeo Therapeutics Corporation Compositions and methods of modulating short-chain dehydrogenase activity

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2838533T (pt) 2012-04-16 2017-11-22 Univ Texas Composições e métodos de modulação da atividade de 15-pgdh
US9801863B2 (en) 2012-04-16 2017-10-31 Case Western Reserve University Inhibitors of short-chain dehydrogenase activity for modulating hematopoietic stem cells and hematopoiesis
AU2014342811B2 (en) 2013-10-15 2019-01-03 Board Of Regents Of The University Of Texas System Compositions and methods of modulating short-chain dehydrogenase activity
AU2016229918B2 (en) 2015-03-08 2020-10-29 Case Western Reserve University Inhibitors of short-chain dehydrogenase activity for treating fibrosis
AU2017300377B2 (en) * 2016-07-18 2022-04-21 Case Western Reserve University Inhibitors of short-chain dehydrogenase activity for promoting neurogenesis and inhibiting nerve cell death
US11426420B2 (en) 2017-04-07 2022-08-30 Case Western Reserve University Inhibitors of short-chain dehydrogenase activity for treating coronary disorders
WO2019195565A1 (en) * 2018-04-04 2019-10-10 Case Western Reserve University Compositions and methods for treating renal injury
JP7532385B2 (ja) 2019-01-31 2024-08-13 杏林製薬株式会社 15-pgdh阻害薬
GB2599292A (en) * 2019-06-11 2022-03-30 Univ Leland Stanford Junior Methods of rejuvenating aged tissue by inhibiting 15-hydroxyprostaglandin dehydrogenase (15-PGDH)
AU2021224268A1 (en) * 2020-02-21 2022-09-15 Case Western Reserve University Compositions and methods for treating renal injury
PE20230777A1 (es) * 2020-05-20 2023-05-09 Rodeo Therapeutics Corp Composiciones y metodos para modular la actividad de deshidrogenasas de cadena corta
WO2022087631A1 (en) * 2020-10-23 2022-04-28 The Board Of Trustees Of The Leland Stanford Junior University Elevation of mitochondrial biogenesis and function by inhibition of prostaglandin degrading enzyme 15-pgdh
AU2021396543A1 (en) * 2020-12-09 2023-07-06 The Board Of Trustees Of The Leland Stanford Junior University Inhibition of prostaglandin degrading enzyme 15-pgdh to improve joint structure and function
US20250154162A1 (en) * 2022-01-28 2025-05-15 Scinnohub Pharmaceutical Co., Ltd. Compound for regulating and controlling 15-pgdh activity and preparation method therefor
US20250250283A1 (en) * 2022-04-13 2025-08-07 Scinnohub Pharmaceutical Co., Ltd. Compound capable of regulating and controlling activity of 15-pgdh, and preparation method therefor
TW202419452A (zh) * 2022-11-11 2024-05-16 大陸商賽諾哈勃藥業(成都)有限公司 調控15-pgdh活性的化合物、其藥物組合物及其用途
WO2024104317A1 (zh) * 2022-11-14 2024-05-23 武汉人福创新药物研发中心有限公司 抑制15-pgdh的化合物及其用途
TW202446380A (zh) * 2023-05-19 2024-12-01 大陸商成都倍特藥業股份有限公司 一種調控15-pgdh活性的化合物、包含其的藥物組合物及它們的用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904672A (en) * 1987-01-30 1990-02-27 Merck & Co., Inc. Derivatives of 3-hydroxyazabenzo[b]thiophene useful as 5-lipoxygenase inhibitors
US6281227B1 (en) * 1996-12-13 2001-08-28 Aventis Pharma Deutschland Gmbh Sulfonic acid sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
SI1373259T1 (en) * 2001-03-30 2005-04-30 Pfizer Products Inc. Pyridazinone aldose reductase inhibitors
ES2294330T3 (es) * 2002-08-02 2008-04-01 MERCK & CO., INC. Derivados de furo(2,3-b)piridina sustituidos.
US7645881B2 (en) * 2004-07-22 2010-01-12 Ptc Therapeutics, Inc. Methods for treating hepatitis C
KR101402474B1 (ko) * 2006-04-26 2014-06-19 제넨테크, 인크. 포스포이노시티드 3-키나제 억제제 화합물 및 이를 포함하는 약학적 조성물
US20100093764A1 (en) * 2008-10-13 2010-04-15 Devraj Chakravarty AMINES AND SULFOXIDES OF THIENO[2,3-d]PYRIMIDINE AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS
US8637558B2 (en) * 2008-12-30 2014-01-28 Industry-Academic Cooperation Foundation, Chosun University Thiazolidinedione derivative and use thereof
PT2838533T (pt) * 2012-04-16 2017-11-22 Univ Texas Composições e métodos de modulação da atividade de 15-pgdh
US9801863B2 (en) * 2012-04-16 2017-10-31 Case Western Reserve University Inhibitors of short-chain dehydrogenase activity for modulating hematopoietic stem cells and hematopoiesis
AU2014342811B2 (en) * 2013-10-15 2019-01-03 Board Of Regents Of The University Of Texas System Compositions and methods of modulating short-chain dehydrogenase activity
AU2016229918B2 (en) * 2015-03-08 2020-10-29 Case Western Reserve University Inhibitors of short-chain dehydrogenase activity for treating fibrosis
JP2019078488A (ja) * 2017-10-25 2019-05-23 ダイキン工業株式会社 空気調和装置

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11690847B2 (en) 2016-11-30 2023-07-04 Case Western Reserve University Combinations of 15-PGDH inhibitors with corticosteroids and/or TNF inhibitors and uses thereof
US11718589B2 (en) 2017-02-06 2023-08-08 Case Western Reserve University Compositions and methods of modulating short-chain dehydrogenase
US12336982B2 (en) 2018-11-21 2025-06-24 Rodeo Therapeutics Corporation Compositions and methods of modulating short-chain dehydrogenase activity

Similar Documents

Publication Publication Date Title
JP2018511616A5 (enExample)
JP2020514323A5 (enExample)
JP2010515731A5 (enExample)
JP2007534702A5 (enExample)
JP2009535307A5 (enExample)
WO2008042240A3 (en) Enantiomerically pure phosphoindoles as hiv inhibitors
NZ593030A (en) Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
JP2004175807A5 (enExample)
WO2009013299A3 (de) Neue bradykinin b1-antagonisten
EA201101671A1 (ru) Замещенные производные аминопропионовой кислоты в качестве ингибиторов неприлизина
SG169338A1 (en) Aryl sulfonamides with an analgesic action
EP2207062A3 (en) Photosensitive compositions, curable compositions, novel compounds, photopolymerizable compositions, color filters, and planographic printing plate precursors
JP2018530582A5 (enExample)
AR048306A1 (es) Derivados de acidos carboxilicos aromaticos con capacidad moduladora de los niveles de insulina, composiciones farmaceuticas que los contienen y su uso en el tratamiento de trastornos metabolicos que responden a la regulacion de gpr40
RU2009139920A (ru) Изоксазолиновые соединения и их применение в борьбе с вредителями
JP2008509166A5 (enExample)
FI2291080T5 (fi) Uusia sfingosiinifosfaattireseptorimodulaattoreita
HRP20110841T1 (hr) Korisni monobaktamski antibiotici
JP2010077141A5 (enExample)
JP2012526082A5 (enExample)
JP2006524660A5 (enExample)
SI2718293T1 (en) SUBSTITUTED PYRIDOPIRAZINS AS NEW INHIBITORS OF VRANIC TYROSIN KINASE (SYK)
RU2013139313A (ru) 6-амино-2-замещенные-5- винилсилилпиримидин-4-карбоновые кислоты и сложные эфиры и 4-амино-6-замещенные-3-винилсилилпиридин-пиколиновые кислоты и сложные эфиры как гербициды
ME02472B (me) Nitrogenovano heterociklično jedinjenje i poljoprivredni ili hortikulturni fungicid
CA2728098A1 (en) Pyrazole-containing tricyclic compounds as_antagonits of an ep1 receptor